Briacell Therapeutics Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$4.13

+0.38 (+10.13%)

As of Mar 30, 10:11 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 4 80%

Hold 1 20%

Sell 0 0%

Price Target

Analyst Price Target +499.3% upside

Low Target $18.09

Average Target $24.75

High Target $34.06

Current Price $4.13

Current
$4.13

Target
$24.75

$18.09 $24.75 avg $34.06

Scenario Analysis

Bear Case

$18.09

338.0%

Low target

Base Case

$24.75

+499.3%

Avg target

Bull Case

$34.06

+724.7%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$135.00

-96.9% from high

52-Week Low

$4.95

+-16.6% from low

Target vs 52W High

$24.75

-81.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%